Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions | 6 Months Ended |
Jul. 03, 2021 | Jul. 04, 2020 |
Cash flows from operating activities | | |
Income (loss) from continuing operations | $ 355 | $ (42) |
Non-cash items: | | |
Depreciation and amortization | 188 | 188 |
Gain on business disposition | (17) | 0 |
Deferred income taxes | 16 | (41) |
Asset impairments and TRU inventory charge | 6 | 110 |
Other, net | 58 | 58 |
Changes in assets and liabilities: | | |
Accounts receivable, net | (38) | 157 |
Inventories | (162) | (244) |
Other assets | 22 | 51 |
Accounts payable | 188 | (400) |
Other liabilities | 103 | 17 |
Income taxes, net | 8 | 3 |
Pension, net | (42) | (8) |
Captive finance receivables, net | 89 | (14) |
Other operating activities, net | (1) | 13 |
Net cash provided by (used in) operating activities of continuing operations | 773 | (152) |
Net cash used in operating activities of discontinued operations | (1) | 0 |
Net cash provided by (used in) operating activities | 772 | (152) |
Cash flows from investing activities | | |
Capital expenditures | (128) | (96) |
Net proceeds from business disposition | 38 | 0 |
Proceeds from the sale of property, plant and equipment | 0 | 5 |
Net proceeds from corporate-owned life insurance policies | 0 | 17 |
Net cash used in acquisitions | 0 | (11) |
Finance receivables repaid | 19 | 20 |
Other investing activities, net | 6 | 1 |
Net cash provided by (used in) investing activities | (65) | (64) |
Cash flows from financing activities | | |
Increase in short-term debt | 0 | 499 |
Net proceeds from long-term debt | 0 | 642 |
Proceeds from borrowings against corporate-owned life insurance policies | 0 | 377 |
Payment On Borrowings Against Corporate Owned Life Insurance | 0 | (15) |
Principal payments on long-term debt and nonrecourse debt | (553) | (229) |
Purchases of Textron common stock | (287) | (54) |
Dividends paid | (9) | (9) |
Other financing activities, net | 75 | 4 |
Net cash provided by (used in) financing activities | (774) | 1,215 |
Effect of exchange rate changes on cash and equivalents | 1 | (10) |
Net increase (decrease) in cash and equivalents | (66) | 989 |
Cash and equivalents at beginning of period | 2,254 | 1,357 |
Cash and equivalents at end of period | 2,188 | 2,346 |
Manufacturing group | | |
Cash flows from operating activities | | |
Income (loss) from continuing operations | 358 | (47) |
Non-cash items: | | |
Depreciation and amortization | 183 | 186 |
Gain on business disposition | (17) | 0 |
Deferred income taxes | 18 | (39) |
Asset impairments and TRU inventory charge | 6 | 110 |
Other, net | 60 | 54 |
Changes in assets and liabilities: | | |
Accounts receivable, net | (38) | 157 |
Inventories | (162) | (244) |
Other assets | 23 | 50 |
Accounts payable | 188 | (400) |
Other liabilities | 103 | 21 |
Income taxes, net | 0 | (1) |
Pension, net | (42) | (8) |
Other operating activities, net | (1) | 13 |
Net cash provided by (used in) operating activities of continuing operations | 679 | (148) |
Net cash used in operating activities of discontinued operations | (1) | 0 |
Net cash provided by (used in) operating activities | 678 | (148) |
Cash flows from investing activities | | |
Capital expenditures | (128) | (96) |
Net proceeds from business disposition | 38 | 0 |
Proceeds from the sale of property, plant and equipment | 0 | 5 |
Net proceeds from corporate-owned life insurance policies | 0 | 17 |
Net cash used in acquisitions | 0 | (11) |
Finance receivables repaid | 0 | 0 |
Finance receivables originated | 0 | 0 |
Other investing activities, net | 0 | 0 |
Net cash provided by (used in) investing activities | (90) | (85) |
Cash flows from financing activities | | |
Increase in short-term debt | 0 | 499 |
Net proceeds from long-term debt | 0 | 642 |
Proceeds from borrowings against corporate-owned life insurance policies | 0 | 377 |
Payment On Borrowings Against Corporate Owned Life Insurance | 0 | (15) |
Principal payments on long-term debt and nonrecourse debt | (519) | (194) |
Purchases of Textron common stock | (287) | (54) |
Dividends paid | (9) | (9) |
Other financing activities, net | 75 | (8) |
Net cash provided by (used in) financing activities | (740) | 1,238 |
Effect of exchange rate changes on cash and equivalents | 1 | (10) |
Net increase (decrease) in cash and equivalents | (151) | 995 |
Cash and equivalents at beginning of period | 2,146 | 1,181 |
Cash and equivalents at end of period | 1,995 | 2,176 |
Finance group | | |
Cash flows from operating activities | | |
Income (loss) from continuing operations | (3) | 5 |
Non-cash items: | | |
Depreciation and amortization | 5 | 2 |
Gain on business disposition | 0 | 0 |
Deferred income taxes | (2) | (2) |
Asset impairments and TRU inventory charge | 0 | 0 |
Other, net | (2) | 4 |
Changes in assets and liabilities: | | |
Accounts receivable, net | 0 | 0 |
Inventories | | 0 |
Other assets | (1) | 1 |
Accounts payable | 0 | 0 |
Other liabilities | 0 | (4) |
Income taxes, net | 8 | 4 |
Pension, net | 0 | 0 |
Other operating activities, net | 0 | 0 |
Net cash provided by (used in) operating activities of continuing operations | 5 | 10 |
Net cash used in operating activities of discontinued operations | 0 | 0 |
Net cash provided by (used in) operating activities | 5 | 10 |
Cash flows from investing activities | | |
Capital expenditures | 0 | 0 |
Net proceeds from business disposition | 0 | 0 |
Proceeds from the sale of property, plant and equipment | 0 | 0 |
Net proceeds from corporate-owned life insurance policies | 0 | 0 |
Net cash used in acquisitions | 0 | 0 |
Finance receivables repaid | 137 | 65 |
Finance receivables originated | (29) | (59) |
Other investing activities, net | 6 | 1 |
Net cash provided by (used in) investing activities | 114 | 7 |
Cash flows from financing activities | | |
Increase in short-term debt | 0 | 0 |
Net proceeds from long-term debt | | 0 |
Proceeds from borrowings against corporate-owned life insurance policies | 0 | 0 |
Payment On Borrowings Against Corporate Owned Life Insurance | 0 | 0 |
Principal payments on long-term debt and nonrecourse debt | (34) | (35) |
Purchases of Textron common stock | 0 | 0 |
Dividends paid | 0 | 0 |
Other financing activities, net | 0 | 12 |
Net cash provided by (used in) financing activities | (34) | (23) |
Effect of exchange rate changes on cash and equivalents | 0 | 0 |
Net increase (decrease) in cash and equivalents | 85 | (6) |
Cash and equivalents at beginning of period | 108 | 176 |
Cash and equivalents at end of period | $ 193 | $ 170 |